Go to main content

Clinical risk factors for speech impairment after posterior fossa tumour surgery in children (2022)

Abstract

Postoperative speech impairment (POSI) is the major component of a severe neurological complication of tumour surgery in the posterior fossa in children known as the cerebellar mutism syndrome.
In a prospective multicentre study, we included 500 children undergoing surgery of a brain tumour in the posterior fossa and followed them over time to detect clinical risk factors for the development of POSI and the subsequent improvement of speech. 
POSI occurred in 30% of our patients. Half of the speech impaired patients regained the ability to speak within 16 days of surgery; however, several patients remained mute for more than 40 days. 
We found that neither transvermian surgical approach, as compared with telovelar approach, nor left-handedness, as compared with right handedness, were associated with a higher risk of POSI. Yet we confirmed that younger children with high-grade tumours located in the midline were at the highest risk. Interestingly, we were the first to report a lower risk of POSI in secondary compared with primary tumour surgery.
These findings most importantly clarify that the decision of type of surgical approach for brain tumour surgery in the posterior fossa in children should not depend on an anticipated risk of POSI.

Place of employment

PhD author

Jonathan Kjær Grønbæk, cand.med, MD, PhD.

Date and place of defense

28 January 2022, Panum

Supervisors

Professor Marianne Juhler, DMSc, MD
Department of Neurosurgery

Professor Kjeld Schmiegelow, DMSc, MD
Astrid Marie Sehested, MD
René Mathiasen, PhD, MD
Karsten Nysom, DMSc, PhD, MD
Morten Arnberg Wibroe, PhD, MD
Department of Paediatrics and Adolescent Medicine 

​Links

PubMed
Last updated:
Responsible editor
Klik for at scrolle op eller ned p� siden G� til toppen af siden